#India #Manipal Hospitals #Aveir Leadless Pacemaker #Cardiac Care #Kolkata

Introduction

Manipal Hospitals has achieved a remarkable milestone in cardiac healthcare by successfully executing the first deployment of an AI-driven, injectable wireless pacemaker in Eastern India. This groundbreaking venture not only sets a precedent in the region but also showcases the hospital's commitment to leading-edge medical technologies that enhance patient care.

The Innovative Procedure

The pacemaker, known as the Aveir Leadless pacemaker, developed by Abbott, was implanted in a 65-year-old patient at the Manipal Hospital located in Dhakuria. This procedure marks the first of its kind in Eastern India, with subsequent operations performed at the Medica Superspecialty Hospital—a unit of Manipal Hospitals—and at Manipal, Mukundapur. The Aveir pacemaker is already in use across the United States and Europe, highlighting its proven safety and efficacy.

Advantages of the Aveir Leadless Pacemaker

One of the key features of this advanced pacemaker is its lightweight design, weighing merely 2.4 grams. With a lifespan extending from 20 to 25 years, it outlasts traditional pacemakers by threefold, significantly enhancing its utility for patients. Additionally, its non-magnetic structure allows it to remain operational in varied environments, including compatibility with airport scanners and MRI machines, thereby preserving the quality of life for patients.

Dr. P.K. Hazra, an Interventional Cardiologist at Manipal Hospital, emphasized the benefits of the Aveir pacemaker. "Unlike previous models of wireless pacemakers that lacked the ability to pace both the atrium and ventricle, this device can transition from a single to a dual-chamber configuration. This capability improves the overall management of the heart's functions without the invasiveness of conventional procedures."

Minimally Invasive Nature

The minimally invasive nature of the Aveir Leadless pacemaker is one of its standout features. It is injected directly into the right ventricle of the heart, which eliminates the necessity for external wires and associated surgical risks. This design is especially beneficial for patients presenting with weakened immunity, skin conditions, or those undergoing treatments like dialysis or on blood thinners—groups traditionally at risk for complications related to surgical procedures.

Dr. Soumya Kanti Dutta, another key interventional cardiologist at Manipal, highlighted the broad implications of this technology. "The reduced requirement for invasive surgeries significantly lowers the risk of infection and other complications. Also, for patients concerned with scarring, this is an ideal solution."

A New Era in Cardiac Care

The introduction of the Aveir Leadless pacemaker in India marks a significant advancement in cardiac therapy. The country is now among the few globally to provide patients with access to this innovative medical device, which has received approvals from both the US FDA and European health authorities.

About Manipal Hospitals

Manipal Hospitals stands as a leader in the Indian healthcare landscape, catering to over seven million patients every year. The institution is committed to delivering high-quality care through a multi-specialty framework. Following the recent acquisition of Medica Synergie and AMRI Hospitals, Manipal's expansive network consists of 37 hospitals across 19 cities in India, boasting over 10,500 beds and a talented team of more than 5,600 medical professionals. The hospitals in this network are recognized for their accreditation standards including NABH and AAHRPP, ensuring excellent healthcare delivery.

In summary, the deployment of the Aveir Leadless pacemaker in Eastern India signifies a transformative leap in cardiac care, embodying Manipal Hospitals' dedication to utilizing technology for improving patient outcomes. The commitment to innovation and quality healthcare will undoubtedly enhance the lives of countless patients going forward.